Visiting CPHI Barcelona?
Schedule a Meet

4-Hydroxy Atorvastatin Lactone D5

Product Information

Product 4-Hydroxy Atorvastatin Lactone D5
CAT No. CS-T-55833
CAS No. 265989-49-9
Status price
Category Stable Isotopes
Hazardous Hazard
Purity Not less than 90%
Controlled No

Product Description

4-Hydroxy Atorvastatin Lactone D5 is a chemical compound that is used in the treatment of high cholesterol and cardiovascular diseases. The active ingredient in this compound is Atorvastatin, which is a commonly prescribed medication for controlling cholesterol levels in the blood. Atorvastatin is a statin drug that works by blocking the enzyme HMG-CoA reductase, which is involved in the synthesis of cholesterol in the liver. 4-Hydroxy Atorvastatin Lactone D5 is a deuterated form of Atorvastatin, meaning that it contains five deuterium atoms. This modification of the compound has several benefits, including increased stability and improved pharmacokinetic properties. The deuterated form of Atorvastatin is also less susceptible to metabolism by the liver, which means that it has a longer half-life in the body and can be more effective at reducing cholesterol levels. The usage of 4-Hydroxy Atorvastatin Lactone D5 is similar to that of regular Atorvastatin. It is typically prescribed as a daily oral medication for the treatment of high cholesterol and other cardiovascular diseases. The recommended dosage and duration of treatment will depend on the individual patient and their medical history. In summary, 4-Hydroxy Atorvastatin Lactone D5 is a deuterated form of Atorvastatin that is used in the treatment of high cholesterol and cardiovascular diseases. It is a potent cholesterol-lowering medication that is well-tolerated by most patients and has a good safety profile.

Additional Information

Packing Product will be supplied in Vials, in certain conditions we also use 'Septa Vials'
Controlled No
Parent API Atorvastatin
Therapeutic Anti-Diabetic
Canonical Smiles CC(C)C1=C(C(=C(N1CCC2CC(CC(=O)O2)O)C3=CC=C(C=C3)F)C4=CC=CC=C4)C(=O)NC5=CC=C(C=C5)O
Inchl InChI=1S/C33H33FN2O5/c1-20(2)31-30(33(40)35-24-12-14-25(37)15-13-24)29(21-6-4-3-5-7-21)32(22-8-10-23(34)11-9-22)36(31)17-16-27-18-26(38)19-28(39)41-27/h3-15,20,26-27,37-38H,16-19H2,1-2H3,(H,35,40)/t26-,27-/m1/s1
IUPAC 5-(4-fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N-(4-hydroxyphenyl)-4-phenyl-2-propan-2-ylpyrrole-3-carboxamide
Hazardous No

Need a Quote?

Your email address will not be published. Required fields are marked *

Safety & Handling Information

General Information Use proper personal protective equipment
Handling Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation.
Engineering Control Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels.
Clothing Wear appropriate protective clothing to minimize contact with skin.
Skin Wear appropriate protective gloves and clothing to prevent skin exposure.
Eyes Wear safety glasses and chemical goggles if splashing is possible.
Inhalation Remove from exposure and move to fresh air immediately.

What we promise?

  • 30-Days Money Back
  • Complete Documentation
  • Worldwide Delivery
  • Product Accuracy

Sample Label

logo 4-Hydroxy Atorvastat... www.clearsynth.com 
 CAT : CS-T-55833 BATCH : CSC-WWW0757

 MF: --
 CAS: 265989-49-9
 Date of Anaysis: 19-Aug-2023
 Retest Date: 19-Jun-2026
MW: --

Store at refrigerator (2-8C)
Qty: 60 MG 
 Only for R & D and Analytical purpose, Not for Human Consumption.

Sample Packaging

Sample Packaging

Sample Vials

Sample Vials
Product List

Related Products